BioXcel Therapeutics, Inc.

The current price of BTAI is 2.59 USD — it has decreased by 4.43% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange BioXcel Therapeutics, Inc. stocks are traded under the ticker BTAI.

BioXcel Therapeutics, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.

BTAI stock is 6.25% volatile and has beta coefficient of 1.14. Check out the list of the most volatile stocks — is BioXcel Therapeutics, Inc. there?

BTAI earnings for the last quarter are −1.72 USD per share, whereas the estimation was −1.27 USD resulting in a −35.02% surprise. The estimated earnings for the next quarter are −0.92 USD per share. See more details about BioXcel Therapeutics, Inc. earnings.

BioXcel Therapeutics, Inc. revenue for the last quarter amounts to ‪341.00 K‬ USD despite the estimated figure of ‪626.00 K‬ USD. In the next quarter revenue is expected to reach ‪742.86 K‬ USD.

Yes, you can track BioXcel Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

BTAI stock has risen by 0.78% compared to the previous week, the month change is a 9.12% fall, over the last year BioXcel Therapeutics, Inc. has showed a 87.67% decrease.

Today BioXcel Therapeutics, Inc. has the market capitalization of ‪100.36 M‬, it has increased by 6.34% over the last week.

No, BTAI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, BTAI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BioXcel Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

BTAI reached its all-time high on Jul 20, 2020 with the price of 71.50 USD, and its all-time low was 1.91 USD and was reached on Feb 9, 2024.
See other stocks reaching their highest and lowest prices.

As of Apr 25, 2024, the company has 74.00 employees. See our rating of the largest employees — is BioXcel Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BioXcel Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BioXcel Therapeutics, Inc. stock shows the sell signal. See more of BioXcel Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on BioXcel Therapeutics, Inc. future price: according to them, BTAI price has a max estimate of 10.00 USD and a min estimate of 3.50 USD. Read a more detailed BioXcel Therapeutics, Inc. forecast: see what analysts think of BioXcel Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BioXcel Therapeutics, Inc. EBITDA is ‪−165.95 M‬ USD, and current EBITDA margin is ‪−12.03 K‬%. See more stats in BioXcel Therapeutics, Inc. financial statements.